Clinical Trial Detail

NCT ID NCT02635360
Title Pembrolizumab and Chemoradiation Treatment for Advanced Cervical Cancer
Recruitment Recruiting
Gender female
Phase Phase II
Variant Requirements No
Sponsors Linda R Duska
Indications

cervical cancer

Therapies

Cisplatin

Pembrolizumab

Age Groups: senior adult

No variant requirements are available.